Navigation Links
Campbell Alliance Brand Management Practice to Discuss Managing Launch Logistics at the EyeForPharma Oncology Summit
Date:1/28/2008

RALEIGH, N.C., Jan. 28 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotechnology industries, today announced that Nader Naeymi-Rad, Senior Vice President of the firm's Brand Management practice, will speak at the EyeForPharma Oncology Summit Europe. The event will be held on January 30-31, 2008, at the Regent's Park Marriott Hotel in London, England.

Mr. Naeymi-Rad's presentation, titled "Key Success Factors for Launching Oncology Products in Europe," is slated for 2:00 pm on January 30 and will cover:

-- The unique characteristics of the oncology market and how they affect a

product launch

-- The nuances of launching products in Europe versus other regions of the

world

-- How best to manage the logistics of a product launch

"Launching a new pharmaceutical product is a complex and challenging undertaking. It becomes significantly more so when that product is an oncologic. The oncology market is complicated and becoming ever more competitive, the products themselves are complex, and launch managers face a wide range of strategic and operational challenges that are not often apparent when launching more traditional drugs in a primary care environment," stated Mr. Naeymi-Rad.

As the head of Campbell Alliance's Brand Management Practice, Mr. Naeymi- Rad is an expert at developing and implementing commercial strategies and improving commercial processes.

For more information on the EyeForPharma Oncology Summit Europe, please visit http://www.eyeforpharma.com/oncology08 .

Executives from Campbell Alliance speak at many conferences in the US and Europe each year. For a full listing of events, please refer to the company's online conference calendar at http://www.campbellal
'/>"/>

SOURCE Campbell Alliance
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Campbell Alliance Trade and Distribution Practice to Chair CBI 3rd Annual Fee for Service and EDI Data Management Conference
2. Campbell Alliance Launches New Practice Area Focused on Trade and Distribution
3. Campbell Alliance Business Development Practice to Moderate Two Workshops at LES Annual Meeting in Vancouver
4. Campbell Alliance Named Best Place to Work by Triangle Business Journal
5. Campbell Alliance Managed Markets Practice to Take Leadership Role at CBIs Formulary and Reimbursement Conference
6. Campbell Alliance to Moderate Senior-Level Panel Discussion at Windhover Pharmaceutical Strategic Alliances Conference
7. Alba Therapeutics Appoints Wendy Perrow as its Vice President, Marketing and Alliance Management
8. Workforce Alliance Concludes Three-Year Biotech Training Program
9. Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
10. Immtech and BioAlliance Sign Licensing Agreement for Pafuramidine
11. Bioenergy Life Science and Integrative Therapeutics, Inc. Form Exclusive Co-Marketing Alliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...s at Singapore,s Institute of Bioengineering and N...of imidazolium salts (IMSs), which suggest that th...nd treatment. , The report on the redox propert...merican Chemical Society . , In a separate study...tion , IBN researchers reported the first use of t...
(Date:12/2/2008)... Ariz., Dec. 2 MedPredict Market R...etitive intelligence and market,research, has pub...nsight for,pharma and biotech companies with a st...erapies. This report, entitled Thought Leader Ins...sed on 9 interviews conducted with PD,experts fro...
(Date:12/2/2008)... Calif., Dec. 2 Bionovo,... focused on the discovery and,development of safe...h and,cancer, announced that Isaac Cohen, Chairma...iew of the Company at the 20th Annual Piper Jaffra...r 3, 2008. The event will be held at,the New Yor...
(Date:12/2/2008)...A, Dec. 2 eResearchTechn...rovider of centralized ECG and eClinical,technolo... biotechnology,medical device and related indust...y, the Company,s President and Chief Executive Off...ncial Officer, are scheduled to present at,the Pi...
Breaking Biology Technology:New uses for imidazolium salts in medicine and alternative energy 2New uses for imidazolium salts in medicine and alternative energy 3New Report Provides Expert Analysis of Recent Advances and Setbacks in Parkinson's Disease Drug Development 2Bionovo to Present at the Piper Jaffray Healthcare Conference 2eResearchTechnology, Inc. to Present at the Piper Jaffray Health Care Conference on December 2, 2008 2
...y Systems Inc. said it has raised $1.4 million in... , ,The company, now about a year old, is developi...generating and using hydrogen fuel in car engines.... method involves generating it from water and suga...ve a chemical reaction. , ,The firm said Advantage...
Culver,s, a fast-food chain native to Wisconsin, is working with Madison Environmental Group on a kit to make cars run on old frying oil. Meanwhile, online extortionists are holding personal files fo
...t tolerating unexpected difference. The boxes tend...a spike in their power curve or an unanticipated c... us that way. The difference, of course, is our ab...e recognize it and choose to do something about it...ok like their pets. Do we begin to look like, act ...
...rket failed to reach double-digit growth in 2004 f... for this focused on concerns over drug safety, pr...products had their patents expire. , ,Let,s take a...the estimates of IMS Health, a pharmaceutical mark...e pharmaceutical market slowed down, one important...
Other Biology Technology:Machine like me 2Machine like me 3Though pharma growth slides, blockbusters reach new record 2Though pharma growth slides, blockbusters reach new record 3
(Date:12/1/2008)...D, Calif. Scientists around the world may benefit...online, that will help them to home in on the part..., Arend Sidow, PhD, associate professor of pathol...ool of Medicine, recently launched the novel bioin...de to determining the role different proteins play...
(Date:12/1/2008)...National Academy of Sciences will hold a colloquiu...es of the nature of niches of organisms. Leading r...predict future patterns of distribution and even e...ology, phylogenetics, and biodiversity informatics...of the Sackler Colloquium series, the event will t...
(Date:12/1/2008)...r, CO, USA The December Geosphere , The Geologic...Topics include detailed data integration from mult...dimentology, and paleontology, to study the southw...ion years ago; sedimentation in a piggyback basin;..., Nevada; and a study of the South Balkan extensio...
(Date:12/1/2008)...IDENCE, R.I. [Brown University] Gray mold is a ga...scientific name Botrytis cinerea , is a scourge t...species, including staples such as tomatoes, straw... endive, peas, peppers, and potatoes. Gray mold en...oxin that poisons the host plants, cells, eventual...
Breaking Biology News(10 mins):Powerful online tool for protein analysis provided pro bono by Stanford geneticist 2Powerful online tool for protein analysis provided pro bono by Stanford geneticist 3December Geosphere media highlights 2December Geosphere media highlights 3Brown chemist finds gray mold's killer gene 2CyberKnife System Achieves 38 Percent Growth in Extracranial Treatments During Fiscal Year 2008 8564 1CyberKnife System Achieves 38 Percent Growth in Extracranial Treatments During Fiscal Year 2008 8564 2CyberKnife System Achieves 38 Percent Growth in Extracranial Treatments During Fiscal Year 2008 8564 3CyberKnife System Achieves 38 Percent Growth in Extracranial Treatments During Fiscal Year 2008 8564 4Angiotech Announces Webcast and Call in Numbers for Annual and Special General Meeting of Shareholders 8561 1Johnson 26 Johnson Pharmaceutical Research 26 Development L L C Submits New Drug Application to FDA for Carisbamate 8559 1Johnson 26 Johnson Pharmaceutical Research 26 Development L L C Submits New Drug Application to FDA for Carisbamate 8559 2Johnson 26 Johnson Pharmaceutical Research 26 Development L L C Submits New Drug Application to FDA for Carisbamate 8559 3Technique for Rapidly Reprogramming Adult Cells Into Stem Cells Published in PLoS Biology 3332 1Technique for Rapidly Reprogramming Adult Cells Into Stem Cells Published in PLoS Biology 3332 2Technique for Rapidly Reprogramming Adult Cells Into Stem Cells Published in PLoS Biology 3332 3
..., a director at the Max Planck Institute of Bioche...the beginning of the 1990s that blocking blood ves... and shrinks its tissue. This fundamental principl...ingredient is Sunitinib. SUTENT® was recently appr... is expected to be brought onto the German market ...
...Comprehensive Cancer Center say that just one, sin...e cancer in mice. The discovery offers new insight...d lymphoma and at the same time underscores the po... RNA play in cell signaling pathways active in car...s is the first direct evidence that overexpression...
...ysed rocks from seabeds millions of years old. Car...ass 12 (99 percent) and atomic mass 13 (1 percent)...were characterised by a relatively strong increase...sed by a sudden large-scale release of carbon from...s. , The atmospheric carbon dioxide concentration...
...ept at blending in with their surroundings, cuttle...terns and can switch between them almost instantan...entists, to appear in the May 2006 issue of the jo...asters of disguise change their appearance based o...olorblind. , While previous research has reported ...
Other Biology News:Basic research leads to a novel cancer therapy 2Basic research leads to a novel cancer therapy 3Basic research leads to a novel cancer therapy 4Single microRNA causes cancer in transgenic mouse 2Single microRNA causes cancer in transgenic mouse 3Carbon cycle was already disrupted millions of years ago 2Cuttlefish masters of disguise despite colorblindness 2
ANTI ALPHA FSH:B
Beagle Serum • Beagle serum is collected from fasted Beagle canines of mixed sex over one year of age Available Anticoagulants: N-02: Citrate N-04: Heparin (Na) N-06: K2EDTA N-08: Pot
MOUSE ANTI HUMAN MBP (67-74) Immunogen: Human myelin basic protein
MOUSE ANTI BOVINE TROPONIN I
Biology Products: